BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 18987565)

  • 1. Voice and choral singing treatment: a new approach for speech and voice disorders in Parkinson's disease.
    Di Benedetto P; Cavazzon M; Mondolo F; Rugiu G; Peratoner A; Biasutti E
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):13-9. PubMed ID: 18987565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Singing in groups for Parkinson's disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders.
    Shih LC; Piel J; Warren A; Kraics L; Silver A; Vanderhorst V; Simon DK; Tarsy D
    Parkinsonism Relat Disord; 2012 Jun; 18(5):548-52. PubMed ID: 22436653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
    Ramig LO; Fox C; Sapir S
    Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ParkinSong: A Controlled Trial of Singing-Based Therapy for Parkinson's Disease.
    Tamplin J; Morris ME; Marigliani C; Baker FA; Vogel AP
    Neurorehabil Neural Repair; 2019 Jun; 33(6):453-463. PubMed ID: 31081485
    [No Abstract]   [Full Text] [Related]  

  • 5. [Communication disorders marked with hypophonia. Indication and speech therapy through the LSVT method].
    Cabaret P; Sarfati J
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(5):325-8. PubMed ID: 20387379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes for professional voice users.
    Wingate JM; Brown WS; Shrivastav R; Davenport P; Sapienza CM
    J Voice; 2007 Jul; 21(4):433-49. PubMed ID: 16581229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying vocal fold vibrations in Parkinson's disease with a nonlinear model.
    Zhang Y; Jiang J; Rahn DA
    Chaos; 2005 Sep; 15(3):33903. PubMed ID: 16252994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voice improvement following conventional speech therapy combined with singing intervention in people with Parkinson's disease: A three-arm randomised controlled trial.
    Mohseni Z; Mohamadi R; Habibi SAH; Saffarian A; Abolghasemi J
    Int J Lang Commun Disord; 2023; 58(5):1752-1767. PubMed ID: 37282797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home-based speech treatment for Parkinson's disease delivered remotely: a case report.
    Constantinescu GA; Theodoros DG; Russell TG; Ward EC; Wilson SJ; Wootton R
    J Telemed Telecare; 2010; 16(2):100-4. PubMed ID: 20008051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease.
    Midi I; Dogan M; Koseoglu M; Can G; Sehitoglu MA; Gunal DI
    Acta Neurol Scand; 2008 Jan; 117(1):26-34. PubMed ID: 18031561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should singing activities be included in speech and voice therapy for prepubertal children?
    Rinta T; Welch GF
    J Voice; 2008 Jan; 22(1):100-12. PubMed ID: 16968664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speech and swallowing disorders in Parkinson disease.
    Sapir S; Ramig L; Fox C
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun; 16(3):205-10. PubMed ID: 18475072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of voice profiles and acoustic signs in patients with Parkinson's disease in North India.
    Lazarus JP; Vibha D; Handa KK; Singh S; Goyal V; Srivastava T; Aggarwal V; Behari M
    J Clin Neurosci; 2012 Aug; 19(8):1125-9. PubMed ID: 22721893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease.
    Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Acoust Soc Am; 2011 Jan; 129(1):350-67. PubMed ID: 21303016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acoustic analysis of parkinsonian speech I: speech characteristics and L-Dopa therapy.
    Goberman AM; Coelho C
    NeuroRehabilitation; 2002; 17(3):237-46. PubMed ID: 12237505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of singing on voice, respiratory control and quality of life in persons with Parkinson's disease.
    Stegemöller EL; Radig H; Hibbing P; Wingate J; Sapienza C
    Disabil Rehabil; 2017 Mar; 39(6):594-600. PubMed ID: 26987751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech treatment for Parkinson's disease.
    Ramig LO; Fox C; Sapir S
    Expert Rev Neurother; 2008 Feb; 8(2):297-309. PubMed ID: 18271714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of Parkinson's-related dysphonia.
    Sewall GK; Jiang J; Ford CN
    Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making non-fluent aphasics speak: sing along!
    Racette A; Bard C; Peretz I
    Brain; 2006 Oct; 129(Pt 10):2571-84. PubMed ID: 16959816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.